BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9579825)

  • 1. The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation.
    Johansson S; Landström M; Hellstrand K; Henriksson R
    Br J Cancer; 1998 Apr; 77(8):1213-9. PubMed ID: 9579825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation.
    Johansson S; Landström M; Henriksson R
    Anticancer Res; 1999; 19(3A):1961-9. PubMed ID: 10470141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
    Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
    Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats.
    Johansson S; Landström M; Bjermer L; Henriksson R
    Prostate; 2000 Mar; 42(4):253-9. PubMed ID: 10679754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2-induced growth inhibition of prostatic adenocarcinoma (Dunning R3327) in rats.
    Henriksson R; Widmark A; Bergh A; Damber JE
    Urol Res; 1992; 20(3):189-91. PubMed ID: 1615579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery of the rat dunning R3327-AT1 prostate tumor.
    Henke K; Hartmann GH; Peschke P; Hahn EW
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):385-91. PubMed ID: 8892464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas.
    Thorndyke C; Meeker BE; Thomas G; Lakey WH; McPhee MS; Chapman JD
    J Urol; 1985 Jul; 134(1):191-8. PubMed ID: 4009821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma.
    Widmark A; Damber JE; Bergh A; Henriksson R
    Prostate; 1994; 24(2):79-83. PubMed ID: 8309847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
    Hillman GG; Maughan RL; Grignon DJ; Yudelev M; Rubio J; Tekyi-Mensah S; Layer A; Che M; Forman JD
    Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals.
    Granfors T; Bergh A; Löfroth PO; Widmark A
    Prostate; 1999 Apr; 39(1):16-22. PubMed ID: 10221261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in rats.
    Hautmann S; Huland E; Huland H
    J Cancer Res Clin Oncol; 1997; 123(11-12):614-8. PubMed ID: 9620219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
    Kager M; Spruss T; Schneider MR; von Angerer E
    J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A
    Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions.
    Pollack A; Ashoori F; Sikes C; Joon DL; von Eschenbach AC; Zagars GK; Meistrich ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):153-8. PubMed ID: 10656387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R
    J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined castration and fractionated radiotherapy in an experimental prostatic adenocarcinoma.
    Granfors T; Damber JE; Bergh A; Landström M; Löfroth PO; Widmark A
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1031-6. PubMed ID: 9392541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.
    Joon DL; Hasegawa M; Sikes C; Khoo VS; Terry NH; Zagars GK; Meistrich ML; Pollack A
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1071-7. PubMed ID: 9276374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.